The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: Evidence for an indirect mechanism

Blood

Volumn 84, Issue 5, 1994, Pages 1534-1542

  Cashman, J D ^a   Eaves, A C ^a   Eaves, C J ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHYLCELLULOSE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SERASPENIDE; SERYLASPARTYLLYSYLPROLINE; TETRAPEPTIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CULTURE; BURST FORMING UNIT E; CELL CYCLE S PHASE; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; COLONY FORMATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROPOIESIS; GRANULOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0028022981     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v84.5.1534.1534     Document Type: Article

References (41)

1. Stein J, Borzillo GV, Rettenmier CW: Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1. Blood 76:1308, 1990
2. Anderson DM, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, Williams DE: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235, 1990
3. Gordon MY, Riley GP, Watt SM, Greaves MF: Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 326:403, 1987
4. Cashman J, Eaves AC, Eaves CJ: Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood 66:1002, 1985
5. Simmons PJ, Torok-Storb B: CD34 expression by stromal precursors in normal human adult bone marrow. Blood 78:2848, 1991
6. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989
7. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE: Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78:666, 1991
8. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96, 1990
9. Hogge DE, Cashman JD, Humphries RK, Eaves CJ: Differential and synergistic effects of human granulocyte-macrophage colony-stimulating factor and human granulocyte colony-stimulating factor on hematopoiesis in human long-term marrow cultures. Blood 77:493, 1991
10. Otsuka T, Thacker JD, Eaves CJ, Hogge DE: Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells. J Clin Invest 88:417, 1991
11. Otsuka T, Thacker JD, Hogge DE: The effects of interleukin 6 and interleukin 3 on early hematopoietic events in long-term cultures of human marrow. Exp Hematol 19:1042, 1991
12. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ: Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 83:5306, 1986
13. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. H. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
14. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P: Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J Immunol 150:3448, 1993
15. Eaves CJ, Cashman JD, Wolpe SD, Eaves AC: Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein-1α, an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci USA 90:12015, 1993
16. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM, Leary AC, Sibley B, Clark SC, Williams DA, Yang Y-C: Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87:7512, 1990
17. Tsuji K, Lyman SD, Sudo T, Clark SC, Ogawa M: Enhancement of murine hematopoiesis by synergistic interactions between Steel factor (ligand for c-kit), Interleukin-11, and other early acting factors in culture. Blood 79:2855, 1992
18. Lyman SD, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
19. Sutherland HJ, Hogge DE, Cook D, Eaves CJ: Alternative mechanisms with and without Steel factor support primitive human hematopoiesis. Blood 81:1465, 1993
20. Guigon M, Bonnet D, Lemoine F, Kobari L, Parmentier C, Yves Mary J, Najman A: Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp Hematol 18:1112, 1990
21. Bonnet D, Cesaire R, Lemoine F, Aoudjhane M, Najman A, Guigon M: The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells. Exp Hematol 20:251, 1992
22. Bonnet D, Lemoine FM, Khoury E, Pradelles P, Najman A, Guigon M: Reversible inhibitory effects and absence of toxicity of the tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture. Exp Hematol 20:1165, 1992
23. Wdzieczak-Bakala J, Fache M-P, Lenfant M, Frindel E, Sainteny F: AcSDKP, an inhibitor of CFU-S proliferation, is synthesized in mice under steady-state conditions and secreted by bone marrow in long-term culture. Leukemia 4:235, 1990
24. Eaves CJ, Eaves AC: Cell culture studies in CML. Baillieres Clin Haematol 1:931, 1987
25. + hemopoietic cells from human bone marrow. J Exp Med 172:363, 1990
26. Eaves CJ, Cashman JD, Eaves AC: Methodology of long-term culture of human hemopoetic cells. J Tissue Culture Methods 13:55, 1991
27. Coulombel L, Eaves AC, Eaves CJ: Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 62:291, 1983
28. Roodman GD, Bird A, Hutzler D, Montgomery W: Tumor necrosis factor-alpha and hematopoietic progenitors: Effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol 15:928, 1987
29. Beran M, O'Brien S, Andersson B, McCredie KB, Gutterman JU: Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells. Hematol Pathol 2:65, 1988
30. Rogers JA, Berman JW: A tumor necrosis factor-responsive long-term-culture-initiating cell is associated with the stromal layer of mouse long-term bone marrow cultures. Proc Natl Acad Sci USA 90:5777, 1993
31. Caux C, Favre C, Saeland S, Ouvert V, Durand I, Mannoni P, Banchereau J: Potentiation of early hematopoiesis by tumor necrosis factor-α is followed by inhibition of granulopoietic differentiation and proliferation. Blood 78:635, 1991
32. 1-S transition of rat hepatocytes. Cell Tissue Kinet 23:99, 1990
33. Lauret E, Dumenil D, Miyanomae T, Sainteny F: Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. II. Unresponsiveness of isolated adult rat hepatocytes, 3T3, FDC-P2, and K562 cell lines to AcSDKP. Possible involvement of intermediary cell(s) in the mechanism of AcSDKP action. Exp Hematol 17:1081, 1989
34. Otsuka T, Eaves CJ, Humphries RK, Hogge DE, Eaves AC: Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells. Leukemia 5:861, 1991
35. Cashman JD, Eaves AC, Eaves CJ: Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-β on normal and leukemic human hematopoietic progenitor cells. Leukemia 6:886, 1992
36. Maciejewski JP, Liu JM, Green SW, Walsh CE, Plumb M, Pragnell IB, Young NS: Expression of stem cell inhibitor (SCI) gene in patients with bone marrow failure. Exp Hematol 20:1112, 1992
37. Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A: Macrophage inflammatory protein (MIP)-1β abrogates the capacity of MIP-1α to suppress myeloid progenitor cell growth. J Immunol 147:2586, 1991
38. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
39. Eaves CJ, Eaves AC: Erythropoiesis, in Golde DW, Takaku F (eds): Hematopoietic Stem Cells. New York, NY, Dekker, 1985, p 19
40. Dunlop DJ, Wright EG, Lorimore S, Graham GJ, Holyoake T, Kerr DJ, Wolpe SD, Pragnell IB: Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1α in vivo. Blood 79:2221, 1992
41. Lord BI, Dexter TM, Clements JM, Hunter MA, Gearing AJH: Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 79:2605, 1992